MOTS-c studies find kidney and eye protection in diabetic mice

The kidney study found both less tissue injury and changes in how cells handled stored fat. ¹ In diabetic mice, MOTS-c treatment was associated with less damage to the tiny tubes that process fluid in the kidneys. ¹ A urine measure called the albumin-to-creatinine ratio, which tracks protein leakage as a sign of kidney injury, was also better preserved. ¹ Kidney tissue contained less fat and fewer immune cells associated with inflammation. ¹ Cells also showed fewer markers of senescence, a state in which stressed cells stop dividing. PubMed

The work points to fat disposal as one part of that protection. ¹ MOTS-c lowered LARS1, a protein that restrains the breakdown of stored fat inside cells. ¹ When kidney cells grown in the lab were made to produce extra LARS1, the protective changes were lost. ¹ In diabetic mice given a blocker of internal cell recycling, much of the kidney protection was also lost. PubMed

The eye study found a better-preserved blood-vessel lining in diabetic mice and human cells grown in the lab. ² Researchers studied the retina, the light-sensing tissue at the back of the eye, and the cells lining its tiny blood vessels. ² High sugar exposure was associated with lower MOTS-c in those vessels. ² With MOTS-c treatment, the vessel barrier was better protected and mitochondria, the cell structures that help supply energy, worked better in the injury models. Nature

The proposed explanation centered on damaged fats rather than stored fat droplets. ² MOTS-c increased PLA2G6, an enzyme involved in processing fats in cell membranes. ² This enzyme helped clear damaged fat molecules linked to injury of the vessel lining. ² When researchers reduced PLA2G6 in cells and mice, the protection was lost. ² The study did not test whether people saw better or lost less vision. Nature

The human study found an association after a heart procedure, not a treatment effect. ³ Researchers enrolled 72 people with acute heart attacks who underwent a procedure to reopen a blocked heart artery. ³ They compared 34 patients with heart injury linked to the loss and return of blood flow against 38 without that injury. ³ MOTS-c in blood taken after the procedure was lower in the injury group. PubMed

The timing of the measurement was important: blood levels before the procedure and levels measured inside the heart's arteries did not show clear differences between groups. ³ The association after the procedure remained after researchers accounted for other measured factors. ³ The blood measurement only modestly separated the groups: its area under the curve, a score for this separation, was 0.648. ³ The data do not show whether the lower level preceded injury, followed it, or reflected another difference between patients. PubMed

A rat-heart experiment tested a different question: whether adding MOTS-c changed injury in the heart tissue itself. ⁴ In isolated rat hearts, researchers temporarily interrupted blood flow and then restored it, a laboratory model of injury associated with a blocked artery. ⁴ MOTS-c was associated with a 73% reduction in infarct size, the amount of heart tissue that died after this interruption. ⁴ That is evidence from an isolated organ, whereas the new human study measured naturally occurring MOTS-c without giving it as a treatment. PubMed+1

The kidney and eye studies also included experiments that disrupted the proposed protective process, making their explanations more specific than a simple association. ¹ The human heart study did not include that kind of experimental test, so it leaves more room for alternative explanations. PubMed

Lower MOTS-c in one illness does not mean that lower levels tell the same story in every condition. ⁵ A 2024 review that combined results from several human studies found lower blood MOTS-c in people with type 2 diabetes, but higher levels in people with obesity. ⁵ These were measurements of the body's own MOTS-c, not trials of administered MOTS-c. ⁵ That contrast makes it difficult to treat a single low or high measurement as a simple measure of protection. BMC

Another laboratory study found that greater metabolic activity (the chemical processes cells use to handle energy and materials) did not necessarily mean better cell repair. ⁶ The researchers studied repair-related cells from human donors with obesity. ⁶ MOTS-c increased metabolic activity, but the cells showed more markers of senescence and weaker repair-related function. ⁶ That does not directly contradict the kidney study, which used different cells under different conditions. ¹ It does limit the idea that MOTS-c has one uniform effect on cellular aging or recovery. PubMed+1

The kidney and eye experiments do not establish human safety or benefit, and the heart study did not administer MOTS-c. ¹ A 2026 review likewise reported no human clinical trials of MOTS-c itself. ⁷ The modest separation between groups in the heart study also leaves the value of MOTS-c as a stand-alone blood test uncertain. PubMed

In the research so far, MOTS-c shows organ protection in laboratory models, while human treatment benefit remains untested. PubMed+2